GlassScriptPhysician profile
Anish Patel
NPI 1467748244
$6,150.27
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Sports Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $889 · 2021: $1,005 · 2022: $4,028 · 2023: $96.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $96.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $96.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Interventional Pain Technologies INC. | $2,768.99 | 2021-2022 | |
| Camber Spine Technologies LLC | $2,059.84 | 2021-2022 | |
| Biotissue Holdings INC. | $876.96 | 2020 | |
| Daiichi Sankyo INC. | $119.79 | 2019 | |
| Stimwave Technologies Incorporated | $100.62 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $86.49 | 2021 | |
| Arcutis Biotherapeutics, INC. | $76.99 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $24.08 | 2019-2020 | |
| Medtronic, INC. | $19.63 | 2023 | Intellis Adaptivestim |
| Biohaven Pharmaceuticals, INC. | $16.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,982.20 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.